Founded in Italy in 1927, SOL Group operates in the area of the production, applied research and marketing of technical and medical gases in the homecare services sector, in the biotechnologies sector and in the production of energy from renewable sources.
With a 2022 turnover of €1.38bn, SOL Group is present in 32 countries with more than 5,700 employees, over 50,000 industrial customers, 500 major medical customers and over 580,000 patients served daily. Parent company SOL Spa has been listed on the Italian Stock Exchange since July 1998.
The main gases produced and distributed by the group are oxygen, nitrogen, argon, hydrogen, carbon dioxide (CO2), sulfur dioxide, acetylene, nitrous oxide, helium, refrigerant gases, liquid natural gas, high purity and specialty gases, medicinal gases and relevant active ingredient as, for instance, nitric oxide.
In the industrial sector, the group supplies compressed, liquefied and cryogenic gases, equipment, systems and services to customers operating in most relevant fields: metallurgy, glass and ceramics, chemistry and pharmaceuticals, food and beverage, oil and gas and services for the environment and transport of goods and people.
... to continue reading you must be subscribed
